ZyVersa Therapeutics, Inc. Quarterly Return On Equity in % from Q4 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
ZyVersa Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2022 to Q3 2024.
  • ZyVersa Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -225 %, a 56.4% decline year-over-year.
  • ZyVersa Therapeutics, Inc. annual Return On Equity for 2023 was -266 %, a 322% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -225 -81.1 -56.4% Sep 30, 2024
Q2 2024 -173 -16.8 -10.8% Jun 30, 2024
Q1 2024 -629 -619 -6242% Mar 31, 2024
Q4 2023 -266 -264 -12587% Dec 31, 2023
Q3 2023 -144 Sep 30, 2023
Q2 2023 -156 Jun 30, 2023
Q1 2023 -9.92 Mar 31, 2023
Q4 2022 -2.09 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.